Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

PV Poll: Processing of EMA MLM Data

Posted on March 16th, 2016 by

Pharmacovigilance

poll-shows

Over the past few months, we have posted blog entries about the EMA Medical Literature Monitoring (MLM) program, including a review of the EMA Annual Update and impressions of the launch phase closure report. Continue reading “PV Poll: Processing of EMA MLM Data” »

ACS San Diego Focuses on Computers + Chemistry

Posted on March 10th, 2016 by

Chemistry

R_D_Solutions_Blog_Image_two_scientists_DIGITAL

As I write this I am getting ready to travel to the 251st ACS National Meeting in San Diego, which starts this Sunday, March 13. I look forward to this year’s event which focuses on a theme that really resonates with me. Kenneth Merz, Jr., San Diego Thematic Program Chair for ACS notes that this year’s meeting: Continue reading “ACS San Diego Focuses on Computers + Chemistry” »

POTUS, Data and How to Increase Your Likelihood of Success

Posted on March 10th, 2016 by

Pharma R&D

success

February 25 marked one year since the advent of the President’s Precision Medicine Initiative and the White House marked the anniversary by hosting a PMI Summit, including a panel discussion in which the POTUS himself Continue reading “POTUS, Data and How to Increase Your Likelihood of Success” »

Catalyzing Decisions in Pharma-Biotech Collaborations

Posted on March 4th, 2016 by

Pharma R&D

collaboration

Despite large strides in technological and scientific progress, the cost to develop and release a new drug has escalated dramatically (1). At the same time, the number of generic drugs has grown in the last decade (2). In the U.S., 70% of Continue reading “Catalyzing Decisions in Pharma-Biotech Collaborations” »

Attack of the Mutants

Posted on March 3rd, 2016 by

Chemistry

lungs, disease

Most parents know how difficult it is to prevent children from taking up bad or unhealthy habits. Children tend to ignore their parents’ advice, convinced as they are that nothing will ever happen to them or their parents are making a fuss about nothing. Continue reading “Attack of the Mutants” »

Validation: The importance of search formulas in Literature Monitoring

Posted on February 29th, 2016 by

Pharmacovigilance

Medical-Literature

A reasonable number of Market Authorization Holders (MAHs) have no ready answer to justify why they use a specific search formula for each specific product when Audit or Inspection time comes: Continue reading “Validation: The importance of search formulas in Literature Monitoring” »

  1. 1
  2. …
  3. 51
  4. 52
  5. 53
  6. 54
  7. 55
  8. …
  9. 60


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.